Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy

Gerard Morton, Merrylee McGuffin, Hans T. Chung, Chia‐Lin Tseng, Joelle Helou, Ananth Ravi, Patrick Cheung, Ewa Szumacher, Stanley K. Liu, William Chu,

Radiotherapy and Oncology · 2020 · 129 citations · 19 references

Concepts

References

19